Antibiotics and chronic kidney disease: Dose adjustment update for infectious disease clinical practice.
Anti-Bacterial Agents
/ administration & dosage
Biotransformation
Dose-Response Relationship, Drug
Drug Monitoring
Evidence-Based Medicine
Humans
Immunocompromised Host
Infectious Disease Medicine
/ methods
Kidney
/ drug effects
Practice Guidelines as Topic
Prescription Drugs
Renal Insufficiency, Chronic
/ metabolism
Antibiotics
Antibiotiques
Insuffisance rénale
Pharmacocinétique
Pharmacokinetics
Renal failure
Journal
Medecine et maladies infectieuses
ISSN: 1769-6690
Titre abrégé: Med Mal Infect
Pays: France
ID NLM: 0311416
Informations de publication
Date de publication:
Jun 2020
Jun 2020
Historique:
received:
21
02
2018
revised:
10
04
2018
accepted:
24
06
2019
pubmed:
22
7
2019
medline:
25
8
2021
entrez:
22
7
2019
Statut:
ppublish
Résumé
Antibiotic prescription in chronic kidney disease patients poses a twofold problem. The appropriate use of antibacterial agents is essential to ensure efficacy and to prevent the emergence of resistance, and dosages should be adapted to the renal function to prevent adverse effects. SiteGPR is a French website for health professionals to help with prescriptions to chronic kidney disease patients. A working group of infectious disease specialists and nephrology pharmacists reviewed the indications, dosing regimens, administration modalities, and dose adjustments of antibiotics marketed in France for patients with renal failure. Data available on the SiteGPR website and detailed in the present article aims to provide an evidence-based update of infectious disease recommendations to health professionals managing patients with chronic kidney disease.
Identifiants
pubmed: 31326299
pii: S0399-077X(18)30100-8
doi: 10.1016/j.medmal.2019.06.010
pii:
doi:
Substances chimiques
Anti-Bacterial Agents
0
Prescription Drugs
0
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
323-331Informations de copyright
Copyright © 2019 Elsevier Masson SAS. All rights reserved.